Neogenomics (NEO) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Neogenomics (NEO) over the last 15 years, with Q4 2024 value amounting to $190.0 million.
- Neogenomics' Accumulated Depreciation & Amortization rose 2008.65% to $190.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $190.0 million, marking a year-over-year increase of 2008.65%. This contributed to the annual value of $190.0 million for FY2024, which is 2008.65% up from last year.
- Neogenomics' Accumulated Depreciation & Amortization amounted to $190.0 million in Q4 2024, which was up 2008.65% from $158.2 million recorded in Q4 2023.
- Neogenomics' 5-year Accumulated Depreciation & Amortization high stood at $190.0 million for Q4 2024, and its period low was $25.9 million during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $123.2 million, with a median of $131.9 million in 2022.
- Per our database at Business Quant, Neogenomics' Accumulated Depreciation & Amortization soared by 32445.95% in 2021 and then surged by 1992.04% in 2023.
- Quarter analysis of 5 years shows Neogenomics' Accumulated Depreciation & Amortization stood at $25.9 million in 2020, then surged by 324.46% to $110.0 million in 2021, then increased by 19.99% to $131.9 million in 2022, then increased by 19.92% to $158.2 million in 2023, then grew by 20.09% to $190.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $190.0 million in Q4 2024, compared to $158.2 million in Q4 2023 and $131.9 million in Q4 2022.